Lidocaine Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Inhibiting NF-κB Activation

Abstract

Lidocaine attenuates LPS-induced lung injury via mechanisms involving inhibiting NF-kappaB activation and cytokine release, which implies that lidocaine may be a potential anti-inflammatory agent in endotoxemia.